Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-02-002804
Filing Date
2002-11-14
Accepted
2002-11-13 17:36:57
Documents
5
Period of Report
2002-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d52559_10k.txt 10-K 311647
3 INDEPENDENT AUDITORS' CONSENT ex23-1.txt EX-23.1 1522
4 EXHIBIT 99.1 d52559_ex99-1.txt EX-99.1 20001
5 EXHIBIT 99.2 d52559_ex99-2.txt EX-99.2 1280
6 EXHIBIT 99.3 d52559_ex99-3.txt EX-99.3 1212
  Complete submission text file 0001169232-02-002804.txt   337649
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 02821125
SIC: 2836 Biological Products, (No Diagnostic Substances)